← back to search

Min Tan

Shanghai Tenth People's Hospital · CN
Area of research
Pulmonary and Respiratory Medicine · Biotechnology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Research and Treatments, RNA modifications and cancer, and Rheumatoid Arthritis Research and Therapies.
h-index
19
citations
1,130
works
89
NIH funding
primary concept
email

Recent publications

LNK promotes granulosa cell apoptosis in PCOS via negatively regulating insulin-stimulated AKT-FOXO3 pathway
Aging 2021cited by 69position: firstdoi
Synthesis and biological evaluation of n-butylphthalide derivatives as anti-platelet aggregation agents
Natural Product Research 2016cited by 11position: middledoi
Neolignans from <i>Aristolochia fordiana</i> Prevent Oxidative Stress-Induced Neuronal Death through Maintaining the Nrf2/HO-1 Pathway in HT22 Cells
Journal of Natural Products 2015cited by 37position: middledoi
Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway
Metabolic Brain Disease 2014cited by 20position: middledoi
Simply combining fasudil and lipoic acid in a novel multitargeted chemical entity potentially useful in central nervous system disorders
RSC Advances 2014cited by 19position: middledoi
Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer
Biochemical and Biophysical Research Communications 2013cited by 77position: firstdoi
Carvedilol, a third-generation β-blocker prevents oxidative stress-induced neuronal death and activates Nrf2/ARE pathway in HT22 cells
Biochemical and Biophysical Research Communications 2013cited by 35position: middledoi
Downregulation of Nrf2/HO-1 pathway and activation of JNK/c-Jun pathway are involved in homocysteic acid-induced cytotoxicity in HT-22 cells
Toxicology Letters 2013cited by 25position: firstdoi
Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
PLoS ONE 2012cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rongbiao Pi · Sun Yat-sen University5 papers (2013–2016)Meihui Chen · Neijiang Normal University4 papers (2013–2014)Ziwei Chen · Nanchang University4 papers (2013–2014)Anmin Liu · Sun Yat-sen University3 papers (2013–2014)Shijun Wen · Tibet University3 papers (2014–2016)Youheng Gao · Guangzhou University of Chinese Medicine2 papers (2013–2014)Peiqing Liu · General Administration of Quality Supervision, Inspection and Quarantine2 papers (2013–2014)Charles Ramassamy · Université Laval2 papers (2013–2014)Ying Ouyang · National University of Defense Technology2 papers (2013–2013)Xiaojuan Chao · University of Kansas Medical Center2 papers (2013–2014)Xingshu Li · Sun Yat-sen University1 papers (2014–2014)Yang Sun · Guangzhou University of Chinese Medicine1 papers (2014–2014)Dongyong Yang · Fujian Medical University1 papers (2021–2021)Yong Cai · Wenzhou Medical University1 papers (2013–2013)Ge Hu · Sun Yat-sen University1 papers (2014–2014)Jianpei Fang · Sun Yat-sen University1 papers (2013–2013) · 1 papers (2012–2012)Yang Ye · Yancheng Teachers University1 papers (2021–2021) · 1 papers (2012–2012)Qinyu Liu · Shanghai Medical College of Fudan University1 papers (2014–2014)